rs12722489 — IL2RA

Intronic variant in IL2RA intron 1 that creates an estrogen-responsive enhancer element — the risk C allele allows estrogen receptor alpha binding and increases IL2RA transcription, altering autoimmune disease susceptibility

See your personal result for IL2RA

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

IL2RA rs12722489 — The Estrogen-Gated Immune Thermostat

The IL2RA gene11 IL2RA gene
IL2RA encodes CD25, the alpha chain of the interleukin-2 receptor, which forms the high-affinity IL-2 receptor complex together with the beta (CD122) and gamma (CD132) chains sits at a critical junction of immune self-tolerance. CD25 is the defining surface marker of regulatory T cells22 regulatory T cells
Tregs are a specialized CD4+ T cell population that suppress immune responses and prevent autoimmunity; CD25 is constitutively expressed at high levels on their surface, giving Tregs preferential access to IL-2 (Tregs), and IL-2 signaling through the high-affinity receptor complex is the master signal for Treg survival, proliferation, and suppressive function. rs12722489 lies within the first intron of IL2RA and controls how much of the receptor gets made — but through an unexpected mechanism involving the sex hormone estrogen.

The Mechanism

Unlike typical intronic variants that quietly affect splicing or have no known function, rs12722489 has been shown to create an allele-specific estrogen response element33 allele-specific estrogen response element
An estrogen response element (ERE) is a short DNA sequence that binds estrogen receptor alpha, driving nearby gene transcription when estrogen is present. The risk C allele (reported as G in coding-strand notation, since IL2RA sits on the minus strand) forms a sequence that binds estrogen receptor alpha (ERα) with high affinity. The protective T allele does not.

Three independent laboratory methods confirmed this: electrophoretic mobility shift assay44 electrophoretic mobility shift assay
EMSA detects protein-DNA binding by showing a band shift when a protein grabs a DNA fragment showed ERα binding to the C-allele sequence but not the T-allele sequence; chromatin immunoprecipitation confirmed endogenous ERα bound the rs12722489 region in live cells; and a luciferase reporter assay55 luciferase reporter assay
Reporter assay: a gene with no cellular function (luciferase) is placed downstream of the test sequence; if the sequence drives transcription, luciferase lights up measurably demonstrated that a 1-kilobase intronic segment containing the C allele enhances promoter activity in a dose-dependent, estrogen-dependent fashion — while the T-allele version of the same segment has no enhancer activity.

The downstream consequence is elevated IL2RA transcription in response to estrogen. This connects two independently recognized phenomena: the strong female predominance of most autoimmune diseases (with estrogen as a key driver) and the role of IL2RA variants in predisposing to them. When estrogen levels are high — throughout most of a woman's reproductive years — the C allele amplifies IL2RA expression in a way the T allele does not. The precise immunological consequences are still being characterized.

The two variants at this locus, rs12722489 and rs2104286, are in moderate linkage disequilibrium66 moderate linkage disequilibrium
r² = 0.62, meaning they are correlated but not identical; they partially tag each other but each captures some independent variation (r² = 0.62). Conditioning analysis in large MS datasets has found that the rs12722489 signal is largely explained by rs2104286, but the estrogen-receptor binding function provides a mechanistic explanation specific to this variant that may become more or less relevant depending on hormonal status.

The Evidence

The MS association was first identified in genome-wide association studies77 genome-wide association studies
The International Multiple Sclerosis Genetics Consortium original GWAS reported the IL2RA locus at P = 2.96 × 10⁻⁸, with rs12722489 among the associated variants of the International Multiple Sclerosis Genetics Consortium and subsequently replicated in two independent European populations88 replicated in two independent European populations
Weber et al. genotyped French and German case-control cohorts totaling over 2,000 individuals; OR range 1.1–1.5. A meta-analysis of six studies99 meta-analysis of six studies
Wang et al. 2018, pooling 4,259 MS cases and 5,420 controls across populations totalling 4,259 MS cases and 5,420 controls established the C allele risk association in Caucasians at OR 1.20 (95% CI 1.12–1.29, p < 0.001), with no significant association in Asians (OR 1.10, 95% CI 0.75–1.63, p = 0.629).

A broader IL2RA heterogeneity study1010 IL2RA heterogeneity study
Maier et al. PLOS Genetics 2009, examining both MS and T1D cohorts examining both MS and type 1 diabetes confirmed the rs12722489 and rs2104286 variants in moderate LD.

The estrogen receptor binding study1111 estrogen receptor binding study
Afanasyeva et al. PLoS One 2017, the definitive molecular characterization of this specific SNP identified rs12722489 as the specific molecular switch, explaining associations observed across rheumatoid arthritis, multiple sclerosis, Crohn's disease, and ulcerative colitis — all diseases that share female predominance and Treg dysfunction as core features.

Practical Implications

The C allele is the common allele in almost every population — roughly 85% of Europeans, 97% of Africans, and 87% of East Asians carry it. Being CC homozygous is the baseline in most populations. The TT genotype (fully protective) is rare (~2% of Europeans) and represents a genuinely unusual configuration.

For CC homozygotes, the risk is real but modest in absolute terms. MS affects roughly 0.1–0.3% of Europeans, and carrying two C alleles raises that approximately 1.4-fold to around 0.14–0.43% — still a low absolute risk.

Interactions

rs12722489 and rs2104286 are two partially independent signals within the same IL2RA intron 1 region. Their r² of 0.62 means they are correlated but not redundant — a subset of individuals will carry the rs12722489 risk allele without the rs2104286 risk allele and vice versa. Fine-mapping studies suggest rs2104286 carries more of the statistical MS signal in large combined analyses, but the estrogen-receptor binding function of rs12722489 may confer distinct effects in females during periods of high estrogen exposure (reproductive years, exogenous estrogen use).

Genotype Interpretations

What each possible genotype means for this variant.

TT Optimal IL2RA Regulation Normal

Two protective alleles — no estrogen-responsive enhancer

You carry two copies of the protective T allele at rs12722489. This is a rare genotype — approximately 2% of Europeans and less than 1% of Africans share it. The T allele does not form a functional estrogen receptor binding site in the IL2RA intron, so IL2RA transcription in this region is not enhanced by estrogen signaling. Your autoimmune risk from this specific variant is at the reference level — modestly below average compared to the common CC genotype. This does not eliminate autoimmune risk from other genetic and environmental factors, but you do not carry the IL2RA risk that the majority of the population carries.

CT Intermediate Autoimmune Risk Intermediate

One risk allele — heterozygous ERα binding at IL2RA

You carry one copy of the C risk allele and one copy of the protective T allele at rs12722489. This heterozygous state corresponds to approximately 19% of the global population, and roughly 26% of Europeans. One C allele creates a single functional estrogen receptor alpha binding site in the IL2RA intron, producing an intermediate level of estrogen-dependent IL2RA transcriptional enhancement. The meta-analysis OR of 1.20 per C allele indicates heterozygotes carry approximately 20% elevated relative risk for multiple sclerosis compared to TT homozygotes, with similar modest elevations for inflammatory bowel disease associations.

CC Elevated Autoimmune Risk High Risk

Two risk alleles — ERα-responsive IL2RA enhancer fully active

You carry two copies of the C allele at rs12722489, the allele that creates a functional estrogen receptor alpha binding site in the IL2RA first intron. This genotype is common — approximately 72% of Europeans share it — yet it carries a meaningful association with multiple autoimmune conditions. The C allele enhances IL2RA transcription in an estrogen-dependent manner. The meta-analysis OR of 1.20 per C allele (compounding for two copies) translates to roughly 1.44-fold elevated relative risk for multiple sclerosis and similar modest elevation for inflammatory bowel disease compared to the rare TT protective genotype. In absolute terms, these remain low-prevalence diseases.